Souhaitez-vous accéder aux communiqués récents ?

New York, United States, Feb. 03, 2025 (GLOBE NEWSWIRE) -- Viruses including influenza, mumps, measles, and hepatitis can be among the world's deadliest killers. Researchers from all around the...

OCU500 will be administered via inhalation and as a nasal sprayCOVID-19 remains a substantial public health threat in the U.S. and around the worldPhase 1 clinical trial is anticipated to start in 2Q...

Updated Phase 2 data one year after the second vaccine dose, the anti-gE antibody immune response to amezosvatein continues to be non-inferior to Shingrix

Curevo Vaccine will present at the 2025 JPM Healthcare Conference on Wednesday January 15th.

OSLO, Norway and BURLINGAME, Calif., Dec. 10, 2024 (GLOBE NEWSWIRE) -- Accumulus Synergy’s innovative cloud-based data-sharing platform could accelerate access to vaccines and other health...

JUPITER, Fla., Nov. 21, 2024 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (NASDAQ: DYAI), a global biotechnology company, announced today that it has been awarded a $3 million grant from the Gates...

FAYETTEVILLE, Ark., Nov. 19, 2024 (GLOBE NEWSWIRE) -- Pacific Genetech today announced that Hercules is the recipient of the “Vaccine Innovation Of The Year” award in the fourth annual BioTech...

NEWARK, Del, Nov. 18, 2024 (GLOBE NEWSWIRE) -- The global veterinary vaccine adjuvants market is experiencing strong growth, with sales estimated to reach USD 431.4 million in 2024 and projected to...

New preclinical data demonstrates that CMV antigens identified with Evaxion’s AI-Immunology™ platform trigger targeted immune responses Results also showcase the successful design of a proprietary...

$189.3 million of cash, cash equivalents and marketable securities as of September 30, 2024 The company is exploring the potential for continued development of its norovirus vaccine candidates in...